Established in 2004 and headquartered in Surat, India, Ami Organics Limited specializes in the research, development, production, and global distribution of pharmaceutical intermediates. The company boasts an extensive catalog of approximately 520 distinct pharma intermediates, crucial for the synthesis of both regulated and generic active pharmaceutical ingredients (APIs). These APIs are applied in a broad array of therapeutic areas, including treatments for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant conditions, alongside new chemical entity development. Beyond pharmaceuticals, Ami Organics also supplies specialty chemicals for sectors such as agrochemicals, cosmetics, and polymers. Their product line further encompasses parabens, parabens formulations, salicylic acid, and other specialized chemicals, which are integral to the cosmetics, dyes, polymers, agrochemical, animal feed, and personal care industries. The company actively exports a significant portion of its manufactured products internationally.